Form 13-F position report

IDEAYA BIOSCIENCES INC

Reported by Boxer Capital LLC

Company profile Manager portfolio Source filing
IDYA CUSIP 45166A102 Manager CIK 0001465837
Latest reported change

Reported 2,202,812 shares, unchanged from the prior quarter.

Reported value -20.0%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 4.07% This manager · Q2 2024
Shares 2,202,812 Quarter-end amount reported
Reported value $77,340,729 Fair value at quarter end
Consecutive quarters held 21 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q4 2024 Reduced 0 -2,202,812 (-100.0%) 0 $0 2025-02-14
Q3 2024 Unchanged 2,202,812 0 (0.0%) 3.42% $69,785,084 2024-11-14
Q2 2024 Unchanged 2,202,812 0 (0.0%) 4.07% $77,340,729 2024-08-14
Q1 2024 Unchanged 2,202,812 0 (0.0%) 4.77% $96,659,391 2024-05-15
Q4 2023 Unchanged 2,202,812 0 (0.0%) 3.91% $78,376,051 2024-02-14
Q3 2023 Unchanged 2,202,812 0 (0.0%) 3.16% $59,431,868 2023-11-14
Q2 2023 Unchanged 2,202,812 0 (0.0%) 2.4% $51,766,000 2023-08-14
Q1 2023 Unchanged 2,202,812 0 (0.0%) 1.49% $30,245,000 2023-05-15
Q4 2022 Unchanged 2,202,812 0 (0.0%) 2.11% $40,025,094 2023-02-14
Q3 2022 Unchanged 2,202,812 0 (0.0%) 1.85% $32,866,000 2022-11-14
Q2 2022 Unchanged 2,202,812 0 (0.0%) 1.93% $30,399,000 2022-08-15
Q1 2022 Unchanged 2,202,812 0 (0.0%) 1.27% $24,649,000 2022-05-16
Q4 2021 Unchanged 2,202,812 0 (0.0%) 2.02% $52,074,000 2022-02-14
Q3 2021 Unchanged 2,202,812 0 (0.0%) 1.96% $56,150,000 2021-11-15
Q2 2021 Unchanged 2,202,812 0 (0.0%) 1.63% $46,237,000 2021-08-16
Q1 2021 Unchanged 2,202,812 0 (0.0%) 1.76% $51,766,000 2021-05-17
Q4 2020 Unchanged 2,202,812 0 (0.0%) 0.99% $30,839,000 2021-02-16
Q3 2020 Unchanged 2,202,812 0 (0.0%) 0.96% $27,667,000 2020-11-16
Q2 2020 Added 2,202,812 +1,438,560 (188.2%) 1.38% $31,302,000 2020-08-14
Q1 2020 Unchanged 764,252 0 (0.0%) 0.21% $3,149,000 2020-05-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

232 managers reported IDEAYA BIOSCIENCES INC for Q2 2024.

Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 11,270,083 +1,114,829 0.03% $395,692,626 14 qtrs
BlackRock Inc Added 6,807,790 +842,377 < 0.01% $239,021,508 21 qtrs
FEDERATED HERMES INC Reduced 4,855,790 -288 0.4% $170,486,787 16 qtrs
VANGUARD GROUP INC Added 4,266,773 +111,016 < 0.01% $149,806,400 21 qtrs
JANUS HENDERSON GROUP PLC Added 4,076,020 +267,570 0.08% $143,104,277 12 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 3,743,741 -308,759 0.02% $131,444,000 15 qtrs
STATE STREET CORPORATION Reduced 2,874,296 -289,658 < 0.01% $100,916,533 17 qtrs
Boxer Capital LLC This report Unchanged 2,202,812 0 4.07% $77,340,729 21 qtrs
Capital Research Global Investors Added 2,164,551 +187,681 0.02% $75,997,386 5 qtrs
DEERFIELD MANAGEMENT COMPANY L P SERIES C Reduced 2,097,113 -533,179 1.23% $73,629,637 8 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 14, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
2,202,812
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.